Welcome to our dedicated page for Blackbaud SEC filings (Ticker: BLKB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blackbaud, Inc. (NASDAQ: BLKB) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a software company dedicated to powering social impact. These SEC filings include annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with other exhibits and technical materials.
Current reports on Form 8-K are used by Blackbaud to disclose material events such as the release of unaudited quarterly financial results. For example, recent 8-K filings have attached press releases covering revenue, operating margins, cash flow metrics, non-GAAP financial measures and commentary from company leadership. These filings also describe how Blackbaud uses non-GAAP metrics like adjusted EBITDA, free cash flow and adjusted free cash flow to analyze its operating performance.
Investors reviewing Blackbaud’s 10-K and 10-Q filings can find information on its software portfolio for fundraising, nonprofit financial management, digital giving, grantmaking, corporate social responsibility and education management, as well as risk factors, accounting policies and segment-level details. Over time, these reports help clarify how the company’s AI roadmap, product innovation and capital allocation strategies, including stock repurchase programs, are reflected in its financial statements.
On this page, Stock Titan surfaces Blackbaud’s SEC filings as they become available from EDGAR and pairs them with AI-powered summaries. These summaries are designed to highlight key points from lengthy documents—such as major changes in guidance, updates to non-GAAP definitions, or revisions to prior-period financial statements—so readers can quickly understand what has changed without reading every line. Users can also review insider-related filings like Form 4 when available, to see reported transactions by directors and officers in Blackbaud’s common stock.
Blackbaud, Inc. (BLKB) Form 144 notice: An officer or other person affiliated with the company reported a proposed sale of 4,000 common shares through Merrill Lynch, valued at $266,445.60, with an approximate sale date of 08/29/2025 on NASDAQ. The shares were acquired on 08/01/2023 via vesting of a stock award from Blackbaud, Inc., and the acquisition was compensatory in nature. The filer reports 48,509,032 shares outstanding, so the proposed sale represents a very small fraction of total shares outstanding. No sales by the filer in the past three months were reported. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Rupal S. Hollenbeck, a director of Blackbaud Inc. (BLKB), reported a direct sale of 2,500 common shares on 08/08/2025 at $63.98 per share. After the disposition, the report shows she beneficially owns 7,966 shares directly. The filing records a straightforward, non-derivative disposition reported on Form 4, indicating a routine insider sale rather than any options or complex securities activity.
Blackbaud, Inc. (BLKB) filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Merrill Lynch on the NASDAQ with an aggregate market value of $159,950. The securities were acquired on 08/01/2025 upon the vesting of a stock award from Blackbaud, Inc., and the transaction is described as a compensatory payment. The approximate date of sale is listed as 08/08/2025. The filing also discloses there were no securities sold by the same person in the prior three months and includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
Blackbaud, Inc. (BLKB) director Kristian Talvitie has filed a Form 4 disclosing receipt of 3,670 shares of company common stock on 1 Aug 2025. The shares were granted as a restricted stock award with no purchase price. They will vest in full on 1 Aug 2026 or, if earlier, immediately before the company’s 2026 annual director election, provided Talvitie continues to serve on the board.
Following the grant, Talvitie’s directly held stake increases to 8,053 shares. No derivative securities were reported and there were no sales or dispositions. Because this is a routine, compensation-related award rather than an open-market purchase, the filing has limited signalling impact for investors, though it modestly raises insider alignment.
On 08/01/2025, Blackbaud, Inc. (BLKB) director Bradley L. Pyburn disclosed the award of 3,670 restricted shares of common stock at no cost (Form 4 transaction code “A”) in a filing dated 08/05/2025. Following the grant, Pyburn’s direct ownership rises to 5,269 shares.
The award will vest on 08/01/2026, or immediately before Blackbaud’s 2026 annual director election if earlier, provided he remains a director. No derivative positions or dispositions were reported, indicating a routine equity-based board compensation event with negligible dilution.
What happened: Blackbaud director Rupal S. Hollenbeck acquired 3,670 restricted shares of common stock, recorded as an acquisition with an effective transaction date of 08/01/2025.
Why it matters: The award vests on August 1, 2026 (or earlier immediately prior to the 2026 annual election of directors) only if she remains a director. The shares were issued at no cash price and bring her direct ownership to 10,466 shares.